Mobetron markiert das Ende der abgeschirmten OP's

Consider the situation in front of the mobetron: a patient undergoing surgery had to be transported to a shielded radiation bunker to return for the rest of the surgery after treatment. Inefficient for oncologists and expensive for the hospital. Worse, this has put patients at greater risk.

Fast progress.

By introducing mobility, Mobetron is taking full advantage of the IORT. Radiation therapists and surgical oncologists work together to determine the exact area that radiation requires and to deliver high doses immediately to the affected tissue during cancer surgery. Healthy tissue and surrounding organs remain unaffected. Portability means that the Mobetron can be easily moved between existing operating theaters without investing in the expensive conversions necessary for traditional unshielded radiation therapy devices. Treatment is delivered to the patient and completed in a fraction of the time with fewer side effects and lower recurrence rates. Most importantly, the patient can live on. Better.